Medicine and Dentistry
Cystic Fibrosis
100%
Lung Clearance
62%
COVID-19
59%
Breathing
49%
Patient with Cystic Fibrosis
29%
Silo-Filler's Disease
27%
Inert Gas
24%
Magnetic Resonance Imaging
23%
Respiratory Disease
19%
Infection
19%
Burkholderia Cepacia Complex
17%
Forced Expiratory Volume
15%
Symptom
14%
Spirometry
14%
Dyspnea
14%
Prospective Cohort Study
13%
Antibiotic Therapy
12%
Sputum
12%
Prevalence
11%
Lung Volume
10%
Lung Ventilation
9%
Diseases
9%
Cohort Analysis
9%
Mental Health
9%
Bronchiectasis
9%
Post-COVID-19
8%
Ivacaftor
8%
Mucin
8%
Rebreathing
8%
Von Willebrand Factor Cleaving Proteinase
8%
Coagulopathy
8%
Fibrinolysis
8%
Von Willebrand Factor
8%
Cross-Link
8%
Radioactive Tracer
8%
Observational Study
7%
Anti-biotics
7%
Lung Ventilation Distribution
7%
Lung Transplantation
7%
Cognitive Defect
7%
In Vitro
7%
Carbon Dioxide
6%
Chest
5%
Disease Severity
5%
Disease Exacerbation
5%
Ligation
5%
Tidal Volume
5%
Rehabilitation Engineering
5%
Diagnosis
5%
Functional Residual Capacity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
66%
Burkholderia Cepacia Complex
16%
Infection
15%
Disease
12%
Symptom
11%
Tezacaftor
11%
Prevalence
11%
Lung Disease
9%
Ivacaftor
9%
Cognitive Defect
8%
Acebilustat
8%
Blood Clotting Disorder
8%
Von Willebrand Factor Cleaving Proteinase
8%
Von Willebrand Factor
8%
Antibiotics
8%
Inflammation
7%
SARS Coronavirus
6%
Normal Human
6%
Cystic Fibrosis Transmembrane Conductance Regulator
5%
Cohort Study
5%
Prospective Cohort Study
5%
Dyspnea
5%